India's Ipca Laboratories sinks to 3-yr low after Unichem Lab deal
BENGALURU, April 25 (Reuters) - Shares of Indian pharmaceutical firm Ipca Laboratories IPCA.NS fell as much as 9.1% to a near three-year low on Tuesday, after it agreed to buy a 33.38% stake in Unichem Laboratories UNLB.NS for up to 10.34 billion rupees ($126.3 million). ($1 = 81.8700 Indian rupees) (Reporting by Ashish Chandra in Bengaluru; Editing by Sonia Cheema) ((ashish.chandra@thomsonreuters.com; +91 7982114624;))
Recent news on Ipca Laboratories
See all newsBrief: Ipca Labs March-Quarter Consol Net Profit 3 Billion Rupees
Brief: Ipca Labs Posts Dec-Qtr Consol Net PAT 3.26 Billion Rupees
Brief: IPCA Labs Says US FDA Issues Form 483 With Three Observations
Brief: IPCA Labs Sept-Quarter Consol Net Pat 2.83 Billion Rupees
Brief: IPCA Labs Says To Sell Unit In Ankleshwar For 221.5 Mln Rupees